HKSE - Delayed Quote HKD

WEIGAO GROUP (1066.HK)

5.850
+0.060
+(1.04%)
At close: 4:08:14 PM GMT+8
Loading Chart for 1066.HK
  • Previous Close 5.790
  • Open 5.920
  • Bid 5.830 x --
  • Ask 5.860 x --
  • Day's Range 5.770 - 6.000
  • 52 Week Range 3.600 - 6.540
  • Volume 5,458,841
  • Avg. Volume 11,763,364
  • Market Cap (intraday) 26.34B
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) 12.19
  • EPS (TTM) 0.480
  • Earnings Date Mar 26, 2025
  • Forward Dividend & Yield 0.26 (4.57%)
  • Ex-Dividend Date Jun 2, 2025
  • 1y Target Est 6.67

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The Medical Device Products segment includes safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions. The Orthopedic Products comprises spine, joint, trauma, sports medicine, orthopedic devices, bone repair material, spinal endoscope, PRP treatment consumables, and negative pressure drainage consumables. The Pharma Packaging Products consists prefilled drug delivery system, pharmaceutical packaging consumables, automatic drug delivery system, and pre-filled syringes. The Interventional Products segment offers tumor, vascular, and nursing interventions. The Blood Management Products segment comprises whole blood collection consumables and blood transfusion equipment. The Others segment consists of finance leases and factoring business. The company was founded in 1988 and is based in Weihai, the People's Republic of China.

www.weigaogroup.com

12,719

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 1066.HK

View More

Performance Overview: 1066.HK

Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

1066.HK
27.73%
HANG SENG INDEX (^HSI)
13.54%

1-Year Return

1066.HK
13.58%
HANG SENG INDEX (^HSI)
24.36%

3-Year Return

1066.HK
20.72%
HANG SENG INDEX (^HSI)
13.87%

5-Year Return

1066.HK
48.37%
HANG SENG INDEX (^HSI)
6.00%

Compare To: 1066.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1066.HK

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    26.34B

  • Enterprise Value

    21.91B

  • Trailing P/E

    12.10

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.89

  • Price/Book (mrq)

    1.03

  • Enterprise Value/Revenue

    1.56

  • Enterprise Value/EBITDA

    5.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.79%

  • Return on Assets (ttm)

    4.15%

  • Return on Equity (ttm)

    8.77%

  • Revenue (ttm)

    13.09B

  • Net Income Avi to Common (ttm)

    2.07B

  • Diluted EPS (ttm)

    0.480

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.32B

  • Total Debt/Equity (mrq)

    16.55%

  • Levered Free Cash Flow (ttm)

    1.64B

Research Analysis: 1066.HK

View More

Company Insights: 1066.HK

Research Reports: 1066.HK

View More

People Also Watch